Table 4: Analysis of risk factors associated with complications.

Risk factors for complications ILND valueALNDP value ILND versus ALNC

Age > 60 16/32 (50%)0.0896/14 (42.9%)0.3970.655
Male11 (37.9%)0.79312 (46.2%)0.0330.357
Female 14 (41.2%)2 (13.3%)0.055
Extremity24 (39.3%)0.7628 (29.6%)0.3970.382
Trunk 1 (50%)6 (42.8%)0.849
LVI 7 (58.3%)0.9353 (50%)0.9540.778
Ulceration 13 (48.1%)0.3245 (38.5%)0.2280.131
Breslow > 3.512 (35.3%)0.4415 (29.4%) 0.5910.674
Clark > 420 (42.6%)0.04810 (32.2%)0.6530.201
Positive nodes > 30% 4/12 (25%)0.9353/7 (42.8%)0.5580.783
Melanoma type
 Superficial spreading11 (37.9%)0.7938 (36.4%)0.7470.909
 Nodular7 (43.8%)0.7004 (30.8%)0.7560.474
 Lentigo maligna1 (25%)0.5352 (66.7%)0.2170.270
 Acral lentiginous4 (36.4%)0.804 00.2960.305
 Amelanotic2 (66.7%)0.328 0 0.4660.248